key: cord-1042331-9yyq6eye
authors: Voruz, P.; Allali, G.; Benzakour, L.; Nuber-Champier, A.; Thomasson, M.; Jacot, I.; Pierce, J.; Lalive, P.; Lovblad, K.-O.; Brallaird, O.; Coen, M.; Serratrice, J.; Pugin, J.; Ptak, R.; Guessous, I.; Landis, B.; Assal, F.; Peron, J. A.
title: Long COVID neuropsychological deficits after severe, moderate or mild infection
date: 2021-02-26
journal: nan
DOI: 10.1101/2021.02.24.21252329
sha: ef3cde22780ab32a55b8adb2fa29835e6cf0958a
doc_id: 1042331
cord_uid: 9yyq6eye

Background: There is growing awareness that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can include long-term neuropsychological deficits, even in its mild or moderate respiratory forms. Methods: Standardized neuropsychological, psychiatric, neurological and olfactory tests were administered to 45 patients (categorized according to the severity of their respiratory symptoms during the acute phase) 236.51 (SD: 22.54) days post-discharge following SARS-CoV-2 infection. Results: Deficits were found in all the domains of cognition and the prevalence of psychiatric symptoms was also high in the three groups. The severe performed more poorly on long-term episodic memory and exhibited greater anosognosia. The moderate had poorer emotion recognition, which was positively correlated with persistent olfactory dysfunction. The mild were more stressed, anxious and depressed. Conclusion: The data support the hypothesis that the virus targets the central nervous system (and notably the limbic system), and support the notion of different neuropsychological phenotypes.

In this context, the present study had three main objectives: i) investigate whether 118 SARS-COV-2 causes long-term (6-9 months after the acute phase) neuropsychological 119 deficits, identify the nature of the affected cognitive and psychiatric domains, and determine 120 their impact on quality of life; ii) explore whether cognitive and psychiatric symptoms are a 121 function of the severity of the respiratory symptoms in the acute phase, and whether patients 122 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint 6 who present with moderate or even mild forms also exhibit cognitive dysfunctions and/or 123 psychiatric symptoms; and iii) look for correlations between long-term neuropsychological 124 deficits and psychiatric symptoms resulting from a neurobiological disturbance caused by 125 SARS-CoV-2 and/or personal stressful experience in the context of the global health crisis, 126 but also between these deficits and olfactory functions. To this end, patients underwent a 127 comprehensive neuropsychological assessment probing multiple cognitive domains, emotion 128 recognition, psychiatric symptoms, and olfaction. They were divided into three groups 129 according to the respiratory severity of the disease in the acute phase: severe (intensive care 130 with respiratory assistance), moderate (hospitalized without respiratory assistance), or mild 131 (not hospitalized). 132

Corresponding with our three objectives, we developed three hypotheses. First, we 133 hypothesized that SARS-CoV-2 causes long-term neuropsychological deficits that continue to 134 affect patients' functioning and quality of life 6-9 months post-infection. We expected to 135 observe cognitive deficits in memory, executive function and logical reasoning (Almeria et is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint 7 METHODS 148 Participants (see Table 1 ) 149 Three groups of patients who had been infected with SARS-CoV-2 were included in the 150 study: 15 patients who had been admitted to intensive care during the acute phase of the 151 infection (severe); 15 patients who had been hospitalized but did not require intensive care 152 (moderate); and 15 patients who had tested positive but had not been hospitalized. All the 153 patients had had their infection confirmed by positive polymerase chain reaction (PCR) from 154 nasopharyngeal swab and/or positive serology. On average, the moderate patients had been 155 hospitalized for 9.27 days (± 9.52), and the severe patients for 37.40 days (± 30.50). In 156 comparison with other studies on SARS-CoV-2, the mean duration of hospitalization for the 157 moderate group was somewhat longer, but this was driven by a single patient. The median 158 number of days for this group was 7, which is comparable to that observed in other studies in 159

Switzerland (Regina et al., 2020) . 160

The required number of participants in each group was determined by a power 161 analysis involving the comparison of two means: = 2 × 2 ( 2 + ) (X̅ 1 − X ̅ 2 ) 2 . This analysis was based 162 on the literature evaluating the short-term neuropsychological effects of SARS-CoV-2 on 163 mild patients (Woo et al., 2020). To achieve the desired statistical power (1 -β) of 90% and 164 risk of Type I error (α) of 0.05, results indicated that for a one-sided hypothesis, 13 165 participants were needed in each group. As we planned to perform nonparametric analyses, 166 we had to increase the sample size by 15% (Lehmann, 2012), resulting in 15 participants per 167 group. 168

The three groups were matched for median age (mild = 57 years; moderate = 55 years; 169 severe = 59 years), sociocultural level, and clinical variables. Given the risk factors associated 170 with the severe form of SARS-CoV-2, there were significantly higher proportions of men 171 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint participants were asked to choose one emotion from the list of 14 that best described the 232 emotion played by the actor. 233 Grober and Buschke (RL/RI 16)delayed free recall (score = 0), he/she would exhibit 246 anosognosia for memory dysfunction: 0 (standardized score on episodic memory test) -3 247 (score on self-questionnaire of memory complaints) = -3. SAD scores could therefore range 248 from -3 to 3, and any score below 0 indicated anosognosia. 249 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint

For each neuropsychological test, we first compared patients' performances with normative 291 data for the validated neuropsychological tools. As the standardization depended upon the 292 distribution of the normative data collected from the reference sample (t and z scores, 293 percentiles, or standard scores), the comparative tests were adjusted according to the 294 guidelines provided by the authors of the validation study for each test. Second, the data were 295 as follows: far below the norm (< 2 nd percentile), substandard (2 nd -5 th percentiles), borderline 298 or below the normal limit (6 th -15 th percentiles), normal (≥ 16 th percentile). This 299 standardization allowed us to quantify the prevalence of each type of disorder, while 300 controlling for variables such as age, education level, and gender. To consider the possible 301 effect of fatigue and increase the robustness of the results, only those performances that were 302 far below the norm (< 2 nd percentile) or substandard (2 nd -5 th percentile) were used to calculate 303 the prevalence of neuropsychological deficits. Results that were just below the norm were 304 therefore not considered in the prevalence table. 305 306

For each neuropsychological, psychiatric or quality-of-life measure, we compared the three 308 groups (severe, moderate, and mild) on the raw data. Given the distribution of the samples, we 309 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint

For each neuropsychological variable of interest, forward stepwise multiple regression 315 analyses were performed on the raw cognitive data with the significant sociodemographic 316 variables, sniff test results and psychiatric measures, to quantify relationships between these 317 variables and the neuropsychological functions. 318

In parallel, and in order to elucidate the cognitive data's underlying structure, we 319 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint

Neuropsychological, psychiatric and olfactory profiles 6-9 months post-327 infection 328

The first aim of this study was to assess the prevalence of neuropsychological impairments 329 and psychiatric symptoms 6-9 months after SARS-CoV-2 infection. We compared patients ' 330 performances with available normative data to identify the number of impaired scores per 331 patient, group, and test. The prevalence of cognitive impairments in each group 236.51 ± 332 22.54 days after infection is set out in Table 2 , and the prevalence of psychiatric symptoms in 333 Table 3  334 Cognition. Cognitive deficits common to all three groups were observed in the 335 following domains: long-term episodic memory in both the verbal and visual modalities, 336 executive functions (e.g., inhibition and mental flexibility, and both categorical and literal 337 verbal fluency), sustained and divided attention, and language (semantic matching and 338 naming). All three groups exhibited anosognosia for executive dysfunction (see Table 2 ) 339

Psychiatric disorders. All three groups displayed anxiety, mania, the social component 340 of apathy, stress, PTSD, and dissociative disorders. All three groups also reported insomnia, 341 fatigue and pathological somnolence (see Table 3 ). The only psychiatric variable where the 342 prevalence score stood out for severe patients was emotional apathy, as measured with AMI 343 (see Table 3 ). 344

Olfaction. 33.33% of the mild group, 73.33% of the moderate group, and 46.66% of 345 the severe group displayed hyposmia. There was no anosmia in the mild and moderate groups, 346 but 13.33% of the severe group were anosmic (see Table 3 ). 347

. CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Emotion recognition GERT -Emotion recognition task (mean ± SD) 26.53 (± 5.14) 20.33 (± 6.17) 21.6 (± 7.23) .023

Note. Prevalence was calculated according to normative scores, ranging from much lower than the norm (below 2 nd percentile) to 1 substandard (between 2 nd and 5 th percentiles). Scores that were borderline or below the normal limit (between 6 th and 15 th percentiles) were not 2 included. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Table 4 ). 97 98 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 105 and other secondary variables 106 The third aim was to examine whether the presence of long-term neuropsychological deficits 107 was correlated with psychiatric symptoms and/or other clinically relevant variables. 108

The results of the multiple regression performed on each cognitive variable are set out 109 in Table 5 . Interestingly, apathy, depression, anxiety, emotion regulation, emotion contagion, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Interestingly, these happened to be precisely the variables on which the three groups differed 129 significantly (see Section "Neuropsychological and psychiatric symptoms as a function of 130 disease severity"). We therefore labeled this component respiratory disease severity. The 131 second component (9.79% of total variance) was labeled attention and anosognosia, as it 132 included alertness, divided attention, and anosognosia for executive dysfunction. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

Even though there is growing evidence that SARS-CoV-2 can cause brain damage in the long 163 term, with an impact on cognition even in its mild and moderate forms, to date, the occurrence 164 and nature of such sequelae, the impact of respiratory disease severity in the acute phase, and 165 the relationship between these impairments and psychiatric disorders triggered or exacerbated 166 by the pandemic have not been studied in detail within a single sample of patients. In The prevalence of psychiatric symptoms, regardless of disease severity during the acute 181 phase, was also high, and individuals in all three groups exhibited depressive symptoms, 182 anxiety, mania, apathy, stress, PTSD and dissociative disorders, as well as reporting insomnia, 183 fatigue and pathological somnolence. Regarding olfaction, 33.33% of the mild group, 73.33% 184 of the moderate group, and 46.66% of the severe group were still hyposmic 6-9 months 185 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint following infection, and 13.33% of the severe group were still anosmic. Second, despite the 186 presence of common cognitive deficits across the three groups, some domains of cognition 187 and mood were differentially impacted by the severity of respiratory disease during the acute 188 phase: the severe group performed more poorly than the mild group on long-term episodic 189 memory, and also exhibited more anosognosia for memory dysfunction. The mild group was 190 more depressed, stressed and anxious, and reported more cognitive complaints. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint (Mazza et al., 2020). That said, although the proportion of women was higher for both the 210 mild and moderate groups, the mean depression scores by gender in the mild (women: 13.50 ± 211 9.10; men: 12.57 ± 8.52) and moderate (women: 6.11 ± 5.25; men: 13.33 ± 11.25) groups did 212 not indicate a greater proportion of women with depressive symptoms. Third, stroke is more 213 prevalent in patients after a severe SARS-CoV-2 infection (Merkler et al., 2020; Nannoni et 214 al., 2020), and may have gone unseen during the acute phase. In our study, no patient had any 215 central neurological deficit excluding major stroke, but minor stroke cannot be ruled out. Two 216 patients in the severe group reported mild signs of peripheral neuropathy, which may have 217 been due to their diabetes and not a direct consequence of the SARS-CoV-2 infection, while 218 one patient in the severe group had an unstable gait. Fourth, the absence of a control group 219 prevented us from observing a possible general effect of the pandemic and the resulting public 220 health measures on mental health. In the present study, the analyses of prevalence were based 221 on standardized normative data, allowing us to run comparisons with the normal population. 222

The tests were chosen carefully for their psychometric validity, with adequate sensitivity and 223 specificity. It is interesting to note that in a recent study, our multimodal emotion recognition 224 task (GERT) was administered to 469 participants during the pandemic (Schlegel, von is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The present results demonstrate that cognitive deficits can be observed 6-9 months 233 post-SARS-CoV-2 infection, regardless of the severity of the disease in the acute phase. They 234 corroborate previous observations for the executive, attentional and memory domains, and go 235 one step further, with exhaustive neuropsychological and psychiatric assessments 236 demonstrating impairments in other previously unexplored cognitive and psychiatric domains. 237

Impairments were evident not only in the severe patient group, but also in the moderate and 238 mild groups. These deficits had an impact on quality of life, notably in the mild patients, as 239 evidenced by our results. These findings could be of great importance in understanding the 240 long-term damage and consequences of SARS-CoV-2 infection on cognition and mental 241 health. The relatively high prevalence of certain cognitive and psychiatric disorders, 242 regardless of the severity of the disease in the acute phase, suggests that long-term patient 243 management following SARS-CoV-2 infection may need to be adapted. Importantly, the 244 etiology of these disorders needs to be established, in order to provide people experiencing 245 these long-term sequelae with the best possible care. One potential explanation for these 246 effects, based on observational studies of the psychiatric impact of the pandemic in the 247 general population (Bäuerle et al., 2020) , is that these cognitive deficits result from a stressful 248 or traumatic context. In this case, specific interventions on certain psychiatric variables could 249 considerably reduce their long-term impact on cognition and improve daily functioning. 250

Nevertheless, the present results do not exclude the hypothesis of direct damage of brain 251 networks by SARS-CoV-2 and its neurotropism, as well as indirect neurobiological effects, 252 which could lead to both to psychiatric and neurological disorders. COVID-19 may induce 253 CNS disturbance, and four main pathogenic mechanisms may act in combination: i) direct 254 viral encephalitis, ii) systemic inflammation, iii) peripheral organ dysfunction (liver, kidney, 255 lung), and iv) cerebrovascular changes (Iadecola, Anrather, & Kamel, 2020). At this stage, it 256 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint is difficult to determine whether the cognitive deficits can be regarded as a marker of brain 257 damage, and/or should be linked to psychiatric variables that may themselves result directly 258 from infection with SARS-CoV-2 or else be triggered by the stressful nature of the general 259 pandemic and the individual experience of the disease. 260

Second, this study highlighted the presence of differential cognitive and psychiatric 261 profiles at 6-9 months post-infection as a function of the respiratory severity of the SARS-262

CoV-2 infection in the acute phase. This suggests the existence of different clinical 263 phenotypes. In the identification/discrimination of these phenotypes, different cognitive 264 variables seem to be of interest, starting with cognitive complaints and anosognosia. While 265 the severe patients exhibited anosognosia for their memory dysfunction and greater long-term 266 verbal memory impairment than the mild patients did, the latter had more cognitive is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. were aged about 45-50 years, and there were equal numbers of men and women. No 296 significant medical antecedents were noted, and the majority of them had had mild or 297 moderate respiratory disease. At the cognitive level, they displayed executive and attentional 298 dysfunctions, which could influence other cognitive domains (e.g., memory recall strategies). 299

At the psychiatric level, they had high scores for depressive symptoms, anxiety, insomnia and 300 stress, and more sporadically exhibited PTSD and dissociative disorders. Our results also 301 indicated the presence of a third (mixed) profile combining the symptoms and clinical 302 characteristics of the two previously described profiles. 303 304 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint

Cognitive profile 328 following COVID-19 infection: Clinical predictors leading to neuropsychological 329 impairment

Distinct 331 subtypes of apathy revealed by the apathy motivation index

Psychometric validation of the English and French versions of the Posttraumatic Stress 335

Disorder Checklist for DSM-5 (PCL-5)

Evidence of the COVID-19 virus 337 targeting the CNS: tissue distribution, host-virus interaction, and proposed 338 neurotropic mechanisms

Increased generalized anxiety, depression and distress during the COVID-341 19 pandemic: a cross-sectional study in Germany

Manual for the beck depression inventory-344

CONCLUSION 305 This study unambiguously demonstrates the presence of long-term neuropsychological 306 sequelae following SARS-CoV-2 infection, regardless of the severity of the respiratory 307 disease in the acute phase. Some of the cognitive deficits could be explained by psychiatric 308 variables, emphasizing the importance of considering a broad range of psychiatric symptoms. 309However, not all neuropsychological sequelae could be explained by these variables. The 310 presence of correlations between olfaction, emotion recognition and episodic memory, which 311 share common functional and anatomical substrates, reinforces the hypothesis that the virus 312 targets the CNS (and notably the limbic system). Finally, the data support the notion of 313 different clinical phenotypes, paving the way for clinical guidelines and recommendations for 314 the management of long-term neurological impairment following SARS-CoV-2 infection. 315. CC-BY-ND 4.0 International license It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252329 doi: medRxiv preprint